QGEN

Peers: RVTY BIO TMO DHR A ILMN TECH BDX BRKR QDEL

| Held by: IWR IWD FXH FMDE IWS PBE IWB IYH JQUA SMMD

Index	-
Market Cap	10.37B
Enterprise Value	11.22B
Income	409.32M
Sales	2.10B
Book/sh	16.26
Cash/sh	3.85
Dividend Est.	0.26 (0.53%)
Dividend TTM	0.35 (0.70%)
Dividend Ex-Date	Jul 07, 2026
Dividend Gr. 3/5Y	- -
Payout	12.88%
Employees	5654
IPO	Jun 28, 1996

P/E	25.55
Forward P/E	19.24
PEG	3.04
P/S	4.94
P/B	3.09
P/C	13.06
P/FCF	23.15
EV/EBITDA	15.59
EV/Sales	5.34
Quick Ratio	2.31
Current Ratio	2.85
Debt/Eq	0.49
LT Debt/Eq	0.48
Option/Short	Yes / Yes

EPS (ttm)	1.97
EPS next Y	2.61
EPS next Q	0.63
EPS this Y	2.06%
EPS next Y	7.62%
EPS next 5Y	6.32%
EPS past 3/5Y	-0.15% 3.60%
Sales past 3/5Y	-0.81% 2.25%
EPS Y/Y TTM	9.52%
Sales Y/Y TTM	2.96%
EPS Q/Q	7.13%
Sales Q/Q	0.28%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	3.61% 1.43%

Insider Own	0.60%
Insider Trans	0.00%
Inst Own	76.18%
Inst Trans	-4.07%
ROA	6.99%
ROE	11.93%
ROIC	8.21%
Gross Margin	61.80%
Oper. Margin	24.62%
Profit Margin	19.49%
SMA20	6.27%
SMA50	11.78%
SMA200	18.14%
Trades

Shs Outstand	206.50M
Shs Float	204.83M
Short Float	3.52%
Short Ratio	2.05
Short Interest	7.20M
52W High	57.81 -12.99%
52W Low	32.53 54.64%
Volatility	0.57% 2.89%
ATR (14)	1.11
RSI (14)	72.88
Beta	0.59
Rel Volume	0.82
Avg Volume	3.51M
Volume	2,050,738

Perf Week	0.17%
Perf Month	14.96%
Perf Quarter	21.51%
Perf Half Y	45.47%
Perf YTD	11.97%
Perf Year	6.71%
Perf 3Y	39.36%
Perf 5Y	-9.75%
Perf 10Y	104.06%
Recom	2.83
Target Price	48.38
Prev Close	50.33
Price	50.30
Change %	-0.05%

ConsensusModerate Buy

Avg. Price Target

$46.89

Implied Upside

-6.8%

Analysts14incl. previous ratings

Rating Distribution7 Buy · 7 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 06, 2026	Upgrade	BBarclays	Equal Weight → Overweight	$55	+9.3%
Sep 09, 2026	Resumed	UUBS	Neutral	$47	-6.6%
Jul 14, 2026	Downgrade	BBerenberg	Buy → Hold	$45.50	-9.6%
Jun 25, 2026	Initiated	KKepler	Hold	$38.60	-23.3%
Jun 23, 2026	Upgrade	MMorgan Stanley	Equal-Weight → Overweight	$42	-16.5%
Apr 29, 2026	Upgrade	RRobert W. Baird	Neutral → Outperform	$43	-14.5%
Apr 14, 2026	Downgrade	BBarclays	Overweight → Equal Weight	$44	-12.5%
Mar 13, 2026	Upgrade	DDeutsche Bank	Hold → Buy	$54	+7.3%
Jan 22, 2026	Downgrade	DDeutsche Bank	Buy → Hold	$54	+7.3%
Dec 11, 2025	Downgrade	CCitigroup	Buy → Neutral	$50	-0.6%
Jun 24, 2025	Initiated	BBarclays	Overweight	$55	+9.3%
Apr 04, 2025	Downgrade	RRedburn Atlantic	Buy → Neutral
Feb 19, 2025	Downgrade	RRobert W. Baird	Outperform → Neutral	$52 → $42	-16.5%
Jan 06, 2025	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$48	-4.6%
Dec 10, 2024	Upgrade	JJefferies	Hold → Buy	$42.50 → $54	+7.3%
Oct 17, 2024	Downgrade	HHSBC Securities	Buy → Hold	$49	-2.6%
Jun 27, 2024	Upgrade	WWolfe Research	Peer Perform → Outperform	$50	-0.6%
Dec 19, 2023	Initiated	WWells Fargo	Equal Weight	$44	-12.5%
Dec 13, 2023	Initiated	WWolfe Research	Peer Perform
Dec 07, 2023	Upgrade	GGoldman	Neutral → Buy	$50	-0.6%

Oct-27-26 07:48PM	Qiagen's Rally Raises The Bar As Back-Half Recovery Faces Its First Real Test (Earnings Whispers)
Oct-23-26 09:00AM	Qiagen agrees to private equity takeover (MedTech Dive)
Oct-21-26 05:44PM	QIAGEN reports preliminary Q3 2026 results (Business Wire)
05:43PM	QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer (Business Wire)
Oct-20-26 01:12PM	Qiagen shares surge on report of advanced EQT takeover talks (Investing.com) +5.05%
04:05PM	Loading…
Oct-13-26 04:05PM	QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis (Business Wire)
Oct-06-26 04:05PM	QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery (Business Wire)
Sep-28-26 01:30AM	QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel (Business Wire)
Sep-24-26 04:05PM	QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation (Business Wire)
Sep-17-26 08:32AM	Qiagen Shares Rise 4% Following Report of Private Equity Takeover Interest (InvestorsHub)
Sep-08-26 03:37PM	ILMN Stock Keeps Climbing. Should You Climb On? (Trefis)
Aug-28-26 02:38PM	10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences (PR Newswire)
Aug-27-26 04:05PM	QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction (Business Wire)
Aug-25-26 06:00AM	Qiagen names new CEO (MedTech Dive)
Aug-24-26 10:26AM	Qiagen names Jonathan Pratt as CEO amid takeover talks (Investing.com) -5.20%
09:47AM	Loading…
09:47AM	QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer (Business Wire)
Aug-05-26 05:43PM	Qiagen: Q2 Earnings Snapshot (Associated Press)
Jul-15-26 04:05PM	QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak (Business Wire)
08:48AM	QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast (Business Wire)
Jul-14-26 04:05PM	QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe (Business Wire)
Jul-09-26 01:19PM	QGEN Stock Clocks Biggest Single-Day Gains In Nearly Six Months Investor Optimism Jumps On Report About Takeover Interest (Stocktwits) +10.50%
Jun-23-26 09:33AM	IBM upgrade, SpaceX initiation among today's top calls on Wall Street (The Fly)
Jun-15-26 01:30AM	QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma (Business Wire)
May-20-26 06:22AM	QIAGEN and NVIDIA partner on AI drug discovery (Pharmaceutical Technology)
May-19-26 04:05PM	QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA (Business Wire)
May-12-26 02:00AM	QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting (Business Wire)
May-11-26 12:08AM	Lost Money on Qiagen N.V. (QGEN)? Contact Levi & Korsinsky to Protect Your Rights (Newsfile)
May-07-26 06:00AM	QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing (Business Wire)
May-06-26 05:47PM	Qiagen: Q1 Earnings Snapshot (Associated Press)
04:05PM	QIAGEN Reports Full Results for Q1 2026 (Business Wire)
03:06AM	Loading…
Apr-29-26 03:06AM	Qiagen NV (QGEN) Q1 2026 Earnings Call Highlights: Navigating Mixed Sales with Strong Profitability (GuruFocus.com)
Apr-27-26 04:16PM	QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook (Business Wire) -10.69%
Apr-16-26 04:05PM	QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026 (Business Wire)
Apr-14-26 04:05PM	QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel (Business Wire)
09:53AM	Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls (The Fly)
Mar-20-26 07:30AM	Qiagen Announces Form 20-F Annual Report Filing for 2025 Results (Business Wire)
Mar-19-26 04:05PM	QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention (Business Wire)
Mar-10-26 05:05PM	QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System (Business Wire)
Mar-06-26 11:30AM	Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? (Zacks)
Feb-19-26 08:00AM	Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery (Business Wire)
Feb-06-26 11:07PM	Qiagen Q4 Earnings Call Highlights (MarketBeat)
08:07AM	QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down (Zacks)
Feb-05-26 04:11PM	Qiagen NV (QGEN) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges (GuruFocus.com)
Feb-04-26 07:30PM	Qiagen (QGEN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:55PM	Qiagen (QGEN) Meets Q4 Earnings Estimates (Zacks)
05:04PM	Qiagen guides to at least 5% sales growth in 2026 (Investing.com)
04:59PM	Qiagen: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars (Business Wire)
Feb-03-26 04:05PM	QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 (Business Wire)
Jan-29-26 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-28-26 12:04PM	Activist Fivespan Partners takes 6% stake in Appian (Investing.com)
11:32AM	Are Options Traders Betting on a Big Move in QIAGEN Stock? (Zacks)
10:00AM	Earnings Preview: Qiagen (QGEN) Q4 Earnings Expected to Decline (Zacks)
Jan-26-26 04:05PM	QIAGEN Appoints Mark Stevenson to Supervisory Board (Business Wire)
Jan-24-26 04:30AM	Investing.coms stocks of the week (Investing.com)
Jan-23-26 04:20PM	Analysts consider potential Qiagen deal amid reported strategic review (Investing.com)
09:41AM	Alphabet upgraded, Micron initiated: Wall Streets top analyst calls (TipRanks)
Jan-22-26 04:36PM	Stocks Settle Higher as Global Tensions Cool and the Economy Expands (Barchart)
09:37AM	Alphabet upgraded, Micron initiated: Wall Street's top analyst calls (The Fly)
08:50AM	Hologic Q1 Earnings Preview: How Should You Play the Stock Now? (Zacks)
Jan-21-26 08:11AM	Qiagen Explores Possible Sale After New Buyer Talks: Report (Benzinga)
06:05AM	Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock? (Zacks)
02:25AM	Qiagen (QGEN) Hits 4-Year High as Earnings Loom (Insider Monkey)
Jan-20-26 01:35PM	Stocks Tumble, Treasury Yields Jump To 5-Month Highs: What's Moving Markets Tuesday? (Benzinga) +16.57%
Jan-19-26 09:56AM	QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast (Business Wire)
Jan-14-26 08:05AM	JPM26: Qiagen outlines key priorities to drive momentum in 2026 (Medical Device Network)
Jan-12-26 09:50AM	Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
02:00AM	QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth (Business Wire)
Dec-18-25 11:27AM	QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million (Business Wire)
09:30AM	EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi (Zacks)
Dec-11-25 06:00AM	Companies Are Just Now Tallying Up the Impact of the US Shutdown (Bloomberg)
Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-04-25 11:30AM	Qiagen (QGEN) Up 6.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-26-25 08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
Nov-17-25 09:15AM	Qiagen (QGEN) International Revenue in Focus: Trends and Expectations (Zacks)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-10-25 01:30AM	QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025 (Business Wire)
Nov-07-25 09:40AM	Why Qiagen (QGEN) is a Top Value Stock for the Long-Term (Zacks)
Nov-05-25 04:05PM	Qiagen NV (QGEN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com)
Nov-04-25 04:30PM	Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings (Zacks)
04:15PM	Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
03:09PM	Qiagen: Q3 Earnings Snapshot (Associated Press Finance)
01:04PM	QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase (Business Wire)
01:03PM	QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions (Business Wire)
07:24AM	Qiagen NV (QGEN) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-03-25 07:21AM	Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-30-25 05:05PM	QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025 (Business Wire)
Oct-29-25 10:00AM	Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline (Zacks)
Oct-28-25 05:05PM	QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing (Business Wire)
10:00AM	Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks)
09:30AM	Will Positive Regulatory Updates Further Boost INCY Stock? (Zacks)
Oct-13-25 08:24AM	QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast (Business Wire)
Oct-10-25 08:54AM	Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? (Zacks)
Oct-09-25 11:40AM	QGEN vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
Oct-08-25 08:20AM	Hologic Expands Panther Fusion's Menu With Diagnostic Innovation (Zacks)
Oct-06-25 08:05AM	How to Play HOLX Stock This Breast Cancer Awareness Month? (Zacks)
Oct-02-25 09:15AM	Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker (Zacks)
Oct-01-25 10:17AM	Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing (Zacks)

Show Previous News

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

CFODr. Roland Sackers

CEO & Member of Management BoardMr. Jonathan M. Pratt

Senior VP & Head of Global OperationsMr. Antonio Santos

CIIAMr. Daniel Wendorff CEFA

VP & Head of Corporate CommunicationsMr. John Gilardi

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Qiagen NV

Upgrade your Finviz experience